Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Retained Earnings (2020 - 2025)

Journey Medical's Retained Earnings history spans 6 years, with the latest figure at -$98.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings fell 13.14% year-over-year to -$98.5 million, compared with a TTM value of -$98.5 million through Dec 2025, down 13.14%, and an annual FY2025 reading of -$98.5 million, down 13.14% over the prior year.
  • Retained Earnings for Q4 2025 was -$98.5 million at Journey Medical, down from -$97.2 million in the prior quarter.
  • The five-year high for Retained Earnings was -$17.1 million in Q3 2021, with the low at -$98.5 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$72.5 million, with a median of -$80.7 million recorded in 2023.
  • Year-over-year, Retained Earnings plummeted 859.26% in 2021 and then grew 0.97% in 2024.
  • Tracing DERM's Retained Earnings over 5 years: stood at -$38.9 million in 2021, then crashed by 76.22% to -$68.5 million in 2022, then fell by 5.62% to -$72.4 million in 2023, then dropped by 20.28% to -$87.0 million in 2024, then fell by 13.14% to -$98.5 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Retained Earnings are -$98.5 million (Q4 2025), -$97.2 million (Q3 2025), and -$94.9 million (Q2 2025).